Making Science Group (MAKS) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
7 May, 2026Executive summary
Q1 2026 saw strong revenue and gross margin growth, with continued international expansion and increased adoption of AI-driven solutions.
Financial reporting structure updated to reflect new business segmentation after the sale of Cloud and Cybersecurity in Spain, with four primary segments: Digital Agency, Awake, Raising, and Investments.
Dividend of €2M paid in April 2026, charged to 2025 results.
Workforce reduced to 850 following divestitures and efficiency gains from AI adoption.
Financial highlights
Consolidated Q1 2026 revenue rose 20% year-over-year to €97.2M; gross margin up 9.5% to €17.3M; recurrent EBITDA up 8.5% to €3.3M.
Profitability remains around 20% gross margin; EBITDA margin stable at 19%.
OPEX increased due to geographic expansion, technology investment, and new AI licenses; operational costs up 9.6% year-over-year.
Staff costs increased 3.6%; non-recurring expenses were not material.
Outlook and guidance
2026 expected to deliver profitable, sustained growth, leveraging 2025 investments.
AI products and internal efficiency initiatives to drive organic growth and operational optimization.
Focus remains on profitability, cash flow generation, debt reduction, and cost optimization.
Positive outlook for Investments segment based on product distribution and cost optimization strategies.
Latest events from Making Science Group
- FY 2025 revenue rose 36% to €374M, EBITDA stable, net debt down 78%, focus shifts to digital and AI.MAKS
Q4 202516 Mar 2026 - H1 2025 revenue up 40% to €174.6M, recurring EBITDA €7.7M, international share at 60%.MAKS
Q2 20252 Nov 2025 - Recurring EBITDA nearly doubled in H1 2024, led by strong Spain and international growth.MAKS
Q2 202411 Jul 2025 - Recurring EBITDA up 94% to €10.6M in 9M24, with robust growth and margin expansion.MAKS
Q3 202411 Jul 2025 - 2024 saw 16% revenue growth and 71% EBITDA surge, with strong international momentum.MAKS
Q4 202411 Jul 2025 - Record Q1 2025 EBITDA and 33% revenue growth driven by strong international expansion.MAKS
Q1 202511 Jul 2025 - Record Q1 2025 EBITDA and rapid international growth highlight strong execution and AI-driven strategy.MAKS
Investor Presentation11 Jul 2025